Literature DB >> 21970828

Common neurological co-morbidities in autism spectrum disorders.

Kiran P Maski1, Shafali S Jeste, Sarah J Spence.   

Abstract

PURPOSE OF REVIEW: Autism spectrum disorders (ASDs) are heterogeneous neurodevelopmental disorders associated with various co-morbidities. Neurological co-morbidities include motor impairments, epilepsy, and sleep dysfunction. These impairments have been receiving more attention recently, perhaps because of their significant impact on the behavior and cognitive function of children with ASDs. Here, we review the epidemiology, etiology, and clinical approach to these neurological co-morbidities and highlight future research directions. RECENT
FINDINGS: Motor impairments include stereotypies, motor delays, and deficits, such as dyspraxia, incoordination, and gait problems. Sleep dysfunction typically presents as difficulty with sleep onset and prolonged awakenings during the night. Recent data suggest that abnormalities in melatonin may affect sleep and may be a potential treatment target. There is no classic epilepsy syndrome associated with ASDs. Intellectual disability, syndromic autism, and female sex are specific risk factors. Recent research has focused on identifying the overlapping pathways between these neurological co-morbidities and the core deficits in ASDs, which may have direct and powerful implications for treatment and prognosis.
SUMMARY: Motor impairment, epilepsy, and sleep dysfunction are common neurological co-morbidities in ASDs. Clinicians should be aware that recognition and treatment of these issues may improve the function and outcome of children with ASDs.

Entities:  

Mesh:

Year:  2011        PMID: 21970828      PMCID: PMC4229811          DOI: 10.1097/MOP.0b013e32834c9282

Source DB:  PubMed          Journal:  Curr Opin Pediatr        ISSN: 1040-8703            Impact factor:   2.856


  79 in total

1.  Sleep in children with autism with and without autistic regression.

Authors:  Flavia Giannotti; Flavia Cortesi; Antonella Cerquiglini; Cristina Vagnoni; Donatella Valente
Journal:  J Sleep Res       Date:  2010-08-16       Impact factor: 3.981

2.  Gait patterns in children with autism.

Authors:  Matthew Calhoun; Margaret Longworth; Victoria L Chester
Journal:  Clin Biomech (Bristol, Avon)       Date:  2010-10-12       Impact factor: 2.063

3.  Risk and correlates of autism spectrum disorder in children with epilepsy: a community-based study.

Authors:  Anne T Berg; Sigita Plioplys; Roberto Tuchman
Journal:  J Child Neurol       Date:  2011-03-18       Impact factor: 1.987

4.  Medically refractory epilepsy in autism.

Authors:  Gemma Sansa; Chad Carlson; Werner Doyle; Howard L Weiner; Judith Bluvstein; William Barr; Orrin Devinsky
Journal:  Epilepsia       Date:  2011-04-19       Impact factor: 5.864

Review 5.  Sleep and autism spectrum disorders.

Authors:  Ann M Reynolds; Beth A Malow
Journal:  Pediatr Clin North Am       Date:  2011-06       Impact factor: 3.278

6.  Autism with seizures and intellectual disability: possible causative role of gain-of-function of the inwardly-rectifying K+ channel Kir4.1.

Authors:  Federico Sicca; Paola Imbrici; Maria Cristina D'Adamo; Francesca Moro; Fabrizia Bonatti; Paola Brovedani; Alessandro Grottesi; Renzo Guerrini; Gabriele Masi; Filippo Maria Santorelli; Mauro Pessia
Journal:  Neurobiol Dis       Date:  2011-03-31       Impact factor: 5.996

7.  Analysis of unsupported gait in toddlers with autism.

Authors:  Gianluca Esposito; Paola Venuti; Fabio Apicella; Filippo Muratori
Journal:  Brain Dev       Date:  2010-08-13       Impact factor: 1.961

Review 8.  The neurology of autism spectrum disorders.

Authors:  Shafali S Jeste
Journal:  Curr Opin Neurol       Date:  2011-04       Impact factor: 5.710

9.  Mortality in individuals with autism, with and without epilepsy.

Authors:  Jane Pickett; Ellen Xiu; Roberto Tuchman; Geraldine Dawson; Clara Lajonchere
Journal:  J Child Neurol       Date:  2011-04-06       Impact factor: 1.987

10.  Further evidence of complex motor dysfunction in drug naive children with autism using automatic motion analysis of gait.

Authors:  Maria Nobile; Paolo Perego; Luigi Piccinini; Elisa Mani; Agnese Rossi; Monica Bellina; Massimo Molteni
Journal:  Autism       Date:  2011-04-08
View more
  29 in total

1.  Valproate and sodium butyrate attenuate manganese-decreased locomotor activity and astrocytic glutamate transporters expression in mice.

Authors:  James Johnson; Edward Alain B Pajarillo; Equar Taka; Romonia Reams; Deok-Soo Son; Michael Aschner; Eunsook Lee
Journal:  Neurotoxicology       Date:  2017-06-10       Impact factor: 4.294

2.  The cognitive and behavioral phenotype of the 16p11.2 deletion in a clinically ascertained population.

Authors:  Ellen Hanson; Raphael Bernier; Ken Porche; Frank I Jackson; Robin P Goin-Kochel; LeeAnne Green Snyder; Anne V Snow; Arianne Stevens Wallace; Katherine L Campe; Yuan Zhang; Qixuan Chen; Debra D'Angelo; Andres Moreno-De-Luca; Patrick T Orr; K B Boomer; David W Evans; Stephen Kanne; Leandra Berry; Fiona K Miller; Jennifer Olson; Elliot Sherr; Christa L Martin; David H Ledbetter; John E Spiro; Wendy K Chung
Journal:  Biol Psychiatry       Date:  2014-06-16       Impact factor: 13.382

3.  Correlates and risk markers for sleep disturbance in participants of the Autism Treatment Network.

Authors:  Jill A Hollway; Michael G Aman; Eric Butter
Journal:  J Autism Dev Disord       Date:  2013-12

4.  AMPA receptor antagonist NBQX attenuates later-life epileptic seizures and autistic-like social deficits following neonatal seizures.

Authors:  Jocelyn J Lippman-Bell; Sanjay N Rakhade; Peter M Klein; Makram Obeid; Michele C Jackson; Annelise Joseph; Frances E Jensen
Journal:  Epilepsia       Date:  2013-10-01       Impact factor: 5.864

5.  Initial analysis of peripheral lymphocytic extracellular signal related kinase activation in autism.

Authors:  Craig A Erickson; Balmiki Ray; Logan K Wink; Baindu L Bayon; Ernest V Pedapati; Rebecca Shaffer; Tori L Schaefer; Debomoy K Lahiri
Journal:  J Psychiatr Res       Date:  2016-09-09       Impact factor: 4.791

6.  Access to services, quality of care, and family impact for children with autism, other developmental disabilities, and other mental health conditions.

Authors:  Rini Vohra; Suresh Madhavan; Usha Sambamoorthi; Claire St Peter
Journal:  Autism       Date:  2013-12-18

7.  Comorbidity prevalence, healthcare utilization, and expenditures of Medicaid enrolled adults with autism spectrum disorders.

Authors:  Rini Vohra; Suresh Madhavan; Usha Sambamoorthi
Journal:  Autism       Date:  2016-10-20

8.  Association Between Midpregnancy Polyunsaturated Fatty Acid Levels and Offspring Autism Spectrum Disorder in a California Population-Based Case-Control Study.

Authors:  Kristen Lyall; Gayle C Windham; Nathaniel W Snyder; Rostislav Kuskovsky; Peining Xu; Anna Bostwick; Lucy Robinson; Craig J Newschaffer
Journal:  Am J Epidemiol       Date:  2021-02-01       Impact factor: 4.897

9.  Genetic Testing Experiences Among Parents of Children with Autism Spectrum Disorder in the United States.

Authors:  Shixi Zhao; Wei-Ju Chen; Shweta U Dhar; Tanya N Eble; Oi-Man Kwok; Lei-Shih Chen
Journal:  J Autism Dev Disord       Date:  2019-12

10.  Dyspraxia, motor function and visual-motor integration in autism.

Authors:  M Miller; L Chukoskie; M Zinni; J Townsend; D Trauner
Journal:  Behav Brain Res       Date:  2014-04-15       Impact factor: 3.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.